We report here a case of angiomyomatous hamartoma in the inguinal lymph node in a 33- year-old woman.
Figure 4: Angiomyomatous hamartoma with angiomatous and fat component (HE x200).
Figure 5: SMA immunoreactivity in smooth muscle cells in the lymph node parenchyma (SMA x100).
Angiomyomatous hamartomas were described as lesions that extended from the hilus to the cortex and comprised thick-walled vascular structures distributed within a collagenous stroma, and smooth muscle cells that were randomly distributed in or in close proximity to vascular structures, but not arranged in a fascicular fashion 1. In some cases, angiomyomatous hamartoma included adipose tissue 2,4. Thus, it should be differentiated from lymph node involvement of angiomyolipoma. The smooth muscle cells of angiomyolipoma had a prominent perivascular arrangement and expressed melanoma-associated antigen HMB-45 7. Our case had an adipose tissue component, but the smooth muscle cells did not show HMB-45 immunoreactivity.
Angiomyomatous hamartoma should be differentiated from lymphangiomatosis, which usually involves intrathoracic and intraabdominal lymph nodes, with smooth muscle cells arranged in bundles and groups around the ectatic vascular structures 1. Nodal leiomyomatosis typically involves intraabdominal lymph nodes. It is characterized by proliferation of smooth muscle cells and lacks prominent vascular proliferation particularly resembling uterine leiomyoma.
The pathogenesis of angiomyomatous hamartoma has not yet been explained. Two possible mechanisms have been suggested. According to these hypotheses hamartomatous lesion is either acquired or it represents a reparative reaction against previous nodal inflammation 1. The present case had no history of surgery or inflammation. Recurrences and metastases of angiomyomatous hamartomas have not been reported 1-4. However, a secondary lesion after tumor resection may develop due to impaired lymphatic transport 5.
Recognizing angiomyomatous hamartoma as a rare and benign vascular tumor of lymph nodes is important in discriminating it from other benign and malignant vascular lesions oflymph nodes.
1) Chan JKC, Frizzera G, Fletcher CDM, Rosai J. Primary vascular tumors of lymph nodes other than Kaposi\'s sarcoma. Am J Surg Pathol 1992;16:335-350.
2) Allen PW, Hoffman GJ. Fat in angiomyomatous hamartoma of lymph node. Am J Surg Pathol 1993;17:748-749.
3) Laeng RH, Hotz MA, Borisch B. Angiomyomatous hamartoma of a cervical lymph node combined with haemangiomatoids and vascular transformation of sinuses. Histopathology 1996;29:80-84.
4) Magro G, Grasso S. Angiomyomatous hamartoma of the lymph node: Case report with adipose tissue component. Gen Diagn Pathol 1997;143:247-249.
5) Sakurai Y, Shoji M, Matsubara T, Imazu H, Hasegawa S, Ochiai M, et al. Angiomyomatous hamartoma and associated stromal lesions in the right inguinal lymph node: A case report. Pathol Int 2000;50:655-659.